Current Advances in Genetic Testing for Spinal Muscular Atrophy

Area of Science:

• Genetics
• Molecular Biology
• Clinical Diagnostics

Background:

• Spinal muscular atrophy (SMA) is a prevalent global genetic disorder.
• Accurate genetic testing is crucial for SMA diagnosis and prevention.
• Recent advancements have introduced novel genetic testing methodologies.

Purpose of the Study:

• To review the latest technological innovations in SMA genetic testing.
• To provide recommendations for selecting appropriate genetic testing techniques.
• To optimize the clinical pathway for SMA tertiary prevention.

Main Methods:

• Review of recent technological advancements in genetic testing for SMA.
• Summary of MassArray, digital PCR (dPCR), next-generation sequencing (NGS), and third-generation sequencing (TGS).
• Exploration of implementation strategies for clinical practice.

Main Results:

• New genetic testing methods like MassArray, dPCR, NGS, and TGS are available.
• These technologies offer improved diagnostic and preventive capabilities for SMA.
• Selection of appropriate techniques is key to optimizing SMA management.

Conclusions:

• Technological innovations are transforming SMA genetic testing.
• Rational selection of testing strategies is essential for effective tertiary prevention.
• Optimizing clinical pathways through advanced genetic testing improves patient outcomes.